Skip to main content.


COVID-19 vaccine effective in people receiving cancer treatment, study finds
About 95% of participants achieved a measurable immune response after vaccination, according to study led by a KU School of Medicine professor and published in JAMA Oncology.

Center Creating Lab-On-A-Chip Technology for Medical Tests Wins $6.6 Million in Continued NIH Funding
The Center of BioModular Multi-Scale Systems for Precision Medicine at the KU Medical Center, which develops rapid next-generation tests for a host of human ailments like cancer, stroke and COVID-19, recently earned $6.6 million in continued funding over the next five years from the National Institutes of Health's National Institute of Biomedical Imaging and Bioengineering (NIBIB) as a National Biotechnology Resource (P41) Center.

Andrew and Cecilia Godwin of Leawood are recipients of the 2021 Rich and Judy Billings Spirit of 1912 Award
The annual award, given by the University of Kansas Alumni Association and the Student Alumni Leadership Board, recognizes Jayhawks who consistently display school spirit, pride and tradition.

Study published in NEJM shows breakthrough drug can benefit more people with cystic fibrosis
According to a study published in the New England Journal of Medicine and co-led by Deepika Polineni, M.D., MPH, associate professor of pulmonary, critical care and sleep medicine, Trikafta can provide additional benefits for cystic fibrosis patients who have genetic mutations that made them eligible for previously approved CFTR modulators. 

The field of health care is moving from the inefficient, one-size-fits-all-patients' medicine of today toward the data-driven and customized medicine of tomorrow. We envision a future where diagnosis, prognosis, treatment and prevention are tailored to each patient's unique genetic and phenotypic information.

The vision of the Kansas Institute for Precision Medicine (KIPM) COBRE is to advance education and support discoveries that will transform health care in our region and beyond.